{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T04:23:48Z","timestamp":1750047828886,"version":"3.37.3"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s12033-023-00919-4","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T15:06:06Z","timestamp":1698246366000},"page":"3025-3041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Eicosanoids Signals in SARS-CoV-2 Infection: A Foe or Friend"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-4443","authenticated-orcid":false,"given":"Mohammad Sharifur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-1115","authenticated-orcid":false,"given":"Mohammad Salim","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"issue":"9","key":"919_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Yang, C., Xu, X. F., Xu, W., & Liu, S. W. (2020). Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica., 41(9), 1141\u20131149. https:\/\/doi.org\/10.1038\/s41401-020-0485-4","journal-title":"Acta Pharmacologica Sinica."},{"issue":"27","key":"919_CR2","doi-asserted-by":"publisher","first-page":"E1059","DOI":"10.1503\/cmaj.1095949","volume":"193","author":"D Duong","year":"2021","unstructured":"Duong, D. (2021). Alpha, Beta, Delta, Gamma What\u2019s important to know about SARS-CoV-2 variants of concern? Canadian Medical Association Journal., 193(27), E1059\u2013E1060. https:\/\/doi.org\/10.1503\/cmaj.1095949","journal-title":"Canadian Medical Association Journal."},{"issue":"5","key":"919_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/17512433.2021.1902303","volume":"14","author":"S Rahman","year":"2021","unstructured":"Rahman, S., Montero, M. T. V., Rowe, K., Kirton, R., & Kunik, F., Jr. (2021). Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence. Expert Review of Clinical Pharmacology, 14(5), 601\u2013621. https:\/\/doi.org\/10.1080\/17512433.2021.1902303","journal-title":"Expert Review of Clinical Pharmacology"},{"key":"919_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijid.2021.12.357","volume":"116","author":"F Abdullah","year":"2022","unstructured":"Abdullah, F., Myers, J., Basu, D., Tintinger, G., Ueckermann, V., Mathebula, M., et al. (2022). Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa. International Journal of Infectious Diseases, 116, 38\u201342. https:\/\/doi.org\/10.1016\/j.ijid.2021.12.357","journal-title":"International Journal of Infectious Diseases"},{"key":"919_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","volume":"53","author":"F Coperchini","year":"2020","unstructured":"Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020). The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system. Cytokine & Growth Factor Reviews., 53, 25\u201332. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.003","journal-title":"Cytokine & Growth Factor Reviews."},{"issue":"4","key":"919_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., et al. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine, 8(4), 420\u2013422. https:\/\/doi.org\/10.1016\/S2213-2600(20)30076-X","journal-title":"The Lancet Respiratory Medicine"},{"issue":"5","key":"919_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2011-0392TR","volume":"46","author":"M Bhatia","year":"2012","unstructured":"Bhatia, M., Zemans, R. L., & Jeyaseelan, S. (2012). Role of chemokines in the pathogenesis of acute lung injury. American Journal of Respiratory Cell and Molecular Biology., 46(5), 566\u2013572. https:\/\/doi.org\/10.1165\/rcmb.2011-0392TR","journal-title":"American Journal of Respiratory Cell and Molecular Biology."},{"issue":"6","key":"919_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye, Q., Wang, B., & Mao, J. (2020). The pathogenesis and treatment of the `Cytokine Storm\u2019 in COVID-19. Journal of Infection, 80(6), 607\u2013613. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.037","journal-title":"Journal of Infection"},{"issue":"2","key":"919_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., et al. (2016). Dysregulated Type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host & Microbe., 19(2), 181\u2013193. https:\/\/doi.org\/10.1016\/j.chom.2016.01.007","journal-title":"Cell Host & Microbe."},{"issue":"13","key":"919_CR10","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1084\/jem.20080201","volume":"205","author":"S Herold","year":"2008","unstructured":"Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S., et al. (2008). Lung epithelial apoptosis in influenza virus pneumonia: The role of macrophage-expressed TNF-related apoptosis-inducing ligand. Journal of Experimental Medicine., 205(13), 3065\u20133077. https:\/\/doi.org\/10.1084\/jem.20080201","journal-title":"Journal of Experimental Medicine."},{"issue":"2","key":"919_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003188","volume":"9","author":"K Hogner","year":"2013","unstructured":"Hogner, K., Wolff, T., Pleschka, S., Plog, S., Gruber, A. D., Kalinke, U., et al. (2013). Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLOS Pathogens., 9(2), e1003188. https:\/\/doi.org\/10.1371\/journal.ppat.1003188","journal-title":"PLOS Pathogens."},{"issue":"1","key":"919_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.chom.2013.12.003","volume":"15","author":"IG Rodrigue-Gervais","year":"2014","unstructured":"Rodrigue-Gervais, I. G., Labbe, K., Dagenais, M., Dupaul-Chicoine, J., Champagne, C., Morizot, A., et al. (2014). Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell Host & Microbe, 15(1), 23\u201335. https:\/\/doi.org\/10.1016\/j.chom.2013.12.003","journal-title":"Cell Host & Microbe"},{"issue":"9","key":"919_CR13","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.ajpath.2020.06.010","volume":"190","author":"BD Hammock","year":"2020","unstructured":"Hammock, B. D., Wang, W., Gilligan, M. M., & Panigrahy, D. (2020). Eicosanoids: The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)? The American Journal of Pathology., 190(9), 1782\u20131788. https:\/\/doi.org\/10.1016\/j.ajpath.2020.06.010","journal-title":"The American Journal of Pathology."},{"issue":"3","key":"919_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nri.2016.147","volume":"17","author":"I Jorgensen","year":"2017","unstructured":"Jorgensen, I., Rayamajhi, M., & Miao, E. A. (2017). Programmed cell death as a defence against infection. Nature Reviews Immunology., 17(3), 151\u2013164. https:\/\/doi.org\/10.1038\/nri.2016.147","journal-title":"Nature Reviews Immunology."},{"issue":"5","key":"919_CR15","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1073\/pnas.1803999116","volume":"116","author":"A Gartung","year":"2019","unstructured":"Gartung, A., Yang, J., Sukhatme, V. P., Bielenberg, D. R., Fernandes, D., Chang, J., et al. (2019). Suppression of chemotherapy-induced cytokine\/lipid mediator surge and ovarian cancer by a dual COX-2\/sEH inhibitor. Proceedings of the National Academy of Sciences of the United States of America., 116(5), 1698\u20131703. https:\/\/doi.org\/10.1073\/pnas.1803999116","journal-title":"Proceedings of the National Academy of Sciences of the United States of America."},{"issue":"5","key":"919_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar, R., & Perlman, S. (2017). Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in Immunopathology., 39(5), 529\u2013539. https:\/\/doi.org\/10.1007\/s00281-017-0629-x","journal-title":"Seminars in Immunopathology."},{"issue":"4","key":"919_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00430-006-0019-9","volume":"195","author":"J Scheller","year":"2006","unstructured":"Scheller, J., & Rose-John, S. (2006). Interleukin-6 and its receptor: From bench to bedside. Medical Microbiology and Immunology, 195(4), 173\u2013183. https:\/\/doi.org\/10.1007\/s00430-006-0019-9","journal-title":"Medical Microbiology and Immunology"},{"issue":"2","key":"919_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000756","volume":"6","author":"SL Smits","year":"2010","unstructured":"Smits, S. L., de Lang, A., van den Brand, J. M., Leijten, L. M., van, I.W.F., Eijkemans, M, J., et al. (2010). Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathogens., 6(2), e1000756. https:\/\/doi.org\/10.1371\/journal.ppat.1000756","journal-title":"PLoS Pathogens."},{"issue":"2","key":"919_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10555-020-09889-4","volume":"39","author":"D Panigrahy","year":"2020","unstructured":"Panigrahy, D., Gilligan, M. M., Huang, S., Gartung, A., Cortes-Puch, I., Sime, P. J., et al. (2020). Inflammation resolution: A dual-pronged approach to averting cytokine storms in COVID-19? Cancer and Metastasis Reviews, 39(2), 337\u2013340. https:\/\/doi.org\/10.1007\/s10555-020-09889-4","journal-title":"Cancer and Metastasis Reviews"},{"key":"919_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","volume":"74","author":"M Schroder","year":"2005","unstructured":"Schroder, M., & Kaufman, R. J. (2005). The mammalian unfolded protein response. Annual Review of Biochemistry, 74, 739\u2013789. https:\/\/doi.org\/10.1146\/annurev.biochem.73.011303.074134","journal-title":"Annual Review of Biochemistry"},{"issue":"18","key":"919_CR21","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.1128\/JVI.00659-06","volume":"80","author":"CP Chan","year":"2006","unstructured":"Chan, C. P., Siu, K. L., Chin, K. T., Yuen, K. Y., Zheng, B., & Jin, D. Y. (2006). Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. Journal of Virology., 80(18), 9279\u20139287. https:\/\/doi.org\/10.1128\/JVI.00659-06","journal-title":"Journal of Virology."},{"issue":"20","key":"919_CR22","doi-asserted-by":"publisher","first-page":"10981","DOI":"10.1128\/JVI.01033-07","volume":"81","author":"GA Versteeg","year":"2007","unstructured":"Versteeg, G. A., van de Nes, P. S., Bredenbeek, P. J., & Spaan, W. J. (2007). The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations. Journal of Virology, 81(20), 10981\u201310990. https:\/\/doi.org\/10.1128\/JVI.01033-07","journal-title":"Journal of Virology"},{"issue":"7","key":"919_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/s0092-8674(01)00611-0","volume":"107","author":"H Yoshida","year":"2001","unstructured":"Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., & Mori, K. (2001). XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell, 107(7), 881\u2013891. https:\/\/doi.org\/10.1016\/s0092-8674(01)00611-0","journal-title":"Cell"},{"issue":"21","key":"919_CR24","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.1128\/MCB.23.21.7448-7459.2003","volume":"23","author":"AH Lee","year":"2003","unstructured":"Lee, A. H., Iwakoshi, N. N., & Glimcher, L. H. (2003). XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Molecular and Cellular Biology., 23(21), 7448\u20137459. https:\/\/doi.org\/10.1128\/MCB.23.21.7448-7459.2003","journal-title":"Molecular and Cellular Biology."},{"key":"919_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6499","author":"S Chopra","year":"2019","unstructured":"Chopra, S., Giovanelli, P., Alvarado-Vazquez, P. A., Alonso, S., Song, M., Sandoval, T. A., et al. (2019). IRE1alpha-XBP1 signaling in leukocytes controls prostaglandin biosynthesis and pain. Science. https:\/\/doi.org\/10.1126\/science.aau6499","journal-title":"Science"},{"key":"919_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41420-019-0181-7","volume":"5","author":"CS Shi","year":"2019","unstructured":"Shi, C. S., Nabar, N. R., Huang, N. N., & Kehrl, J. H. (2019). SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov., 5, 101. https:\/\/doi.org\/10.1038\/s41420-019-0181-7","journal-title":"Cell Death Discov."},{"issue":"3","key":"919_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11262-005-0070-4","volume":"33","author":"M Liu","year":"2006","unstructured":"Liu, M., Gu, C., Wu, J., & Zhu, Y. (2006). Amino acids 1 to 422 of the spike protein of SARS associated coronavirus are required for induction of cyclooxygenase-2. Virus Genes, 33(3), 309\u2013317. https:\/\/doi.org\/10.1007\/s11262-005-0070-4","journal-title":"Virus Genes"},{"issue":"8","key":"919_CR28","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.biocel.2006.02.003","volume":"38","author":"X Yan","year":"2006","unstructured":"Yan, X., Hao, Q., Mu, Y., Timani, K. A., Ye, L., Zhu, Y., et al. (2006). Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT\/enhancer binding protein. International Journal of Biochemistry & Cell Biology, 38(8), 1417\u20131428. https:\/\/doi.org\/10.1016\/j.biocel.2006.02.003","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"28","key":"919_CR29","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.1073\/pnas.0503279102","volume":"102","author":"KR Schmelzer","year":"2005","unstructured":"Schmelzer, K. R., Kubala, L., Newman, J. W., Kim, I. H., Eiserich, J. P., & Hammock, B. D. (2005). Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci U S A., 102(28), 9772\u20139777. https:\/\/doi.org\/10.1073\/pnas.0503279102","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7418","key":"919_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature11351","volume":"490","author":"J von Moltke","year":"2012","unstructured":"von Moltke, J., Trinidad, N. J., Moayeri, M., Kintzer, A. F., Wang, S. B., van Rooijen, N., et al. (2012). Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature, 490(7418), 107\u2013111. https:\/\/doi.org\/10.1038\/nature11351","journal-title":"Nature"},{"issue":"4","key":"919_CR31","doi-asserted-by":"publisher","first-page":"204589401988360","DOI":"10.1177\/2045894019883607","volume":"9","author":"B Tielemans","year":"2019","unstructured":"Tielemans, B., Stoian, L., Gijsbers, R., Michiels, A., Wagenaar, A., Farre Marti, R., et al. (2019). Cytokines trigger disruption of endothelium barrier function and p38 MAP kinase activation in BMPR2-silenced human lung microvascular endothelial cells. Pulm Circ., 9(4), 2045894019883607. https:\/\/doi.org\/10.1177\/2045894019883607","journal-title":"Pulm Circ."},{"issue":"2","key":"919_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jmv.20255","volume":"75","author":"KJ Huang","year":"2005","unstructured":"Huang, K. J., Su, I. J., Theron, M., Wu, Y. C., Lai, S. K., Liu, C. C., et al. (2005). An interferon-gamma-related cytokine storm in SARS patients. Journal of Medical Virology., 75(2), 185\u2013194. https:\/\/doi.org\/10.1002\/jmv.20255","journal-title":"Journal of Medical Virology."},{"issue":"6","key":"919_CR33","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1165\/rcmb.2012-0381OC","volume":"48","author":"R Choo-Wing","year":"2013","unstructured":"Choo-Wing, R., Syed, M. A., Harijith, A., Bowen, B., Pryhuber, G., Janer, C., et al. (2013). Hyperoxia and interferon-gamma-induced injury in developing lungs occur via cyclooxygenase-2 and the endoplasmic reticulum stress-dependent pathway. American Journal of Respiratory Cell and Molecular Biology., 48(6), 749\u2013757. https:\/\/doi.org\/10.1165\/rcmb.2012-0381OC","journal-title":"American Journal of Respiratory Cell and Molecular Biology."},{"key":"919_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijid.2020.09.1466","volume":"101","author":"S Baghaki","year":"2020","unstructured":"Baghaki, S., Yalcin, C. E., Baghaki, H. S., Aydin, S. Y., Daghan, B., & Yavuz, E. (2020). COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies. International Journal of Infectious Diseases., 101, 29\u201332. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.1466","journal-title":"International Journal of Infectious Diseases."},{"issue":"8","key":"919_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nri3859","volume":"15","author":"EA Dennis","year":"2015","unstructured":"Dennis, E. A., & Norris, P. C. (2015). Eicosanoid storm in infection and inflammation. Nature Reviews Immunology., 15(8), 511\u2013523. https:\/\/doi.org\/10.1038\/nri3859","journal-title":"Nature Reviews Immunology."},{"issue":"7503","key":"919_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan, C. N. (2014). Pro-resolving lipid mediators are leads for resolution physiology. Nature, 510(7503), 92\u2013101. https:\/\/doi.org\/10.1038\/nature13479","journal-title":"Nature"},{"issue":"1","key":"919_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., et al. (2021). Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets. Signal Transduction and Targeted Therapy, 6(1), 94. https:\/\/doi.org\/10.1038\/s41392-020-00443-w","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"4","key":"919_CR38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10616-013-9616-9","volume":"66","author":"MS Rahman","year":"2014","unstructured":"Rahman, M. S., Khan, F., Syeda, P. K., Nishimura, K., Jisaka, M., Nagaya, T., et al. (2014). Endogenous synthesis of prostacyclin was positively regulated during the maturation phase of cultured adipocytes. Cytotechnology, 66(4), 635\u2013646. https:\/\/doi.org\/10.1007\/s10616-013-9616-9","journal-title":"Cytotechnology"},{"issue":"6","key":"919_CR39","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s10616-016-9960-7","volume":"68","author":"F Khan","year":"2016","unstructured":"Khan, F., Syeda, P. K., Nartey, M. N., Rahman, M. S., Islam, M. S., Nishimura, K., et al. (2016). Stimulation of fat storage by prostacyclin and selective agonists of prostanoid IP receptor during the maturation phase of cultured adipocytes. Cytotechnology, 68(6), 2417\u20132429. https:\/\/doi.org\/10.1007\/s10616-016-9960-7","journal-title":"Cytotechnology"},{"issue":"1\u20134","key":"919_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.prostaglandins.2011.06.002","volume":"95","author":"AA Chowdhury","year":"2011","unstructured":"Chowdhury, A. A., Rahman, M. S., Nishimura, K., Jisaka, M., Nagaya, T., Ishikawa, T., et al. (2011). 15-Deoxy-D12,14-prostaglandin J2 interferes inducible synthesis of prostaglandins E2 and F2a that suppress subsequent adipogenesis program in cultured preadipocytes. Prostaglandins & Other Lipid Mediators., 95(1\u20134), 53\u201362. https:\/\/doi.org\/10.1016\/j.prostaglandins.2011.06.002","journal-title":"Prostaglandins & Other Lipid Mediators."},{"issue":"3\u20134","key":"919_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prostaglandins.2010.12.005","volume":"94","author":"MS Hossain","year":"2011","unstructured":"Hossain, M. S., Chowdhury, A. A., Rahman, M. S., Nishimura, K., Jisaka, M., Nagaya, T., et al. (2011). Development of enzyme-linked immunosorbent assay for \u0394 12-PG2 and its application to the measurement of the endogenous product generated by cultured adipocytes during the maturation phase. Prostaglandins & Other Lipid Mediators., 94(3\u20134), 73\u201380. https:\/\/doi.org\/10.1016\/j.prostaglandins.2010.12.005","journal-title":"Prostaglandins & Other Lipid Mediators."},{"issue":"2","key":"919_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0005-2760(81)90174-0","volume":"663","author":"NK Hopkins","year":"1981","unstructured":"Hopkins, N. K., & Gorman, R. R. (1981). Regulation of 3T3-L1 fibroblast differentiation by prostacyclin (prostaglandin I2). Biochimica et Biophysica Acta., 663(2), 457\u2013466. https:\/\/doi.org\/10.1016\/0005-2760(81)90174-0","journal-title":"Biochimica et Biophysica Acta."},{"issue":"3","key":"919_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.prostaglandins.2007.01.009","volume":"83","author":"L Xu","year":"2007","unstructured":"Xu, L., Miyoshi, H., Nishimura, K., Jisaka, M., Nagaya, T., & Yokota, K. (2007). Gene expression of isoformic enzymes in arachidonate cyclooxygenase pathway and the regulation by tumor necrosis factor alpha during life cycle of adipocytes. Prostaglandins & Other Lipid Mediators, 83(3), 213\u2013218. https:\/\/doi.org\/10.1016\/j.prostaglandins.2007.01.009","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"4","key":"919_CR44","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1002\/jcp.26932","volume":"234","author":"MS Rahman","year":"2019","unstructured":"Rahman, M. S. (2019). Prostacyclin: A major prostaglandin in the regulation of adipose tissue development. Journal of Cellular Physiology, 234(4), 3254\u20133262. https:\/\/doi.org\/10.1002\/jcp.26932","journal-title":"Journal of Cellular Physiology"},{"issue":"4\u20135","key":"919_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000172446","volume":"13","author":"M Schilling","year":"1996","unstructured":"Schilling, M., Gassmann, N., Regli, B., Stoupis, C., & Buckler, M. W. (1996). Increased thromboxane B2 and prostaglandin E2 levels precede clinical acute respiratory distress syndrome after esophageal resection. Digestive Surgery, 13(4\u20135), 273\u2013276.","journal-title":"Digestive Surgery"},{"issue":"1","key":"919_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-4804(85)90154-4","volume":"39","author":"GJ Slotman","year":"1985","unstructured":"Slotman, G. J., Burchard, K. W., & Gann, D. S. (1985). Thromboxane and prostacyclin in clinical acute respiratory failure. Journal of Surgical Research, 39(1), 1\u20137. https:\/\/doi.org\/10.1016\/0022-4804(85)90154-4","journal-title":"Journal of Surgical Research"},{"issue":"3","key":"919_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF00254700","volume":"13","author":"G Deby-Dupont","year":"1987","unstructured":"Deby-Dupont, G., Braun, M., Lamy, M., Deby, C., Pincemail, J., Faymonville, M. E., et al. (1987). Thromboxane and prostacyclin release in adult respiratory distress syndrome. Intensive Care Medicine., 13(3), 167\u2013174.","journal-title":"Intensive Care Medicine."},{"issue":"3","key":"919_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1128\/CVI.00636-12","volume":"20","author":"RV D'Elia","year":"2013","unstructured":"D\u2019Elia, R. V., Harrison, K., Oyston, P. C., Lukaszewski, R. A., & Clark, G. C. (2013). Targeting the \u201ccytokine storm\u201d for therapeutic benefit. Clinical and Vaccine Immunology., 20(3), 319\u2013327. https:\/\/doi.org\/10.1128\/CVI.00636-12","journal-title":"Clinical and Vaccine Immunology."},{"issue":"2","key":"919_CR49","doi-asserted-by":"publisher","first-page":"L266","DOI":"10.1152\/ajplung.00248.2011","volume":"302","author":"H Aso","year":"2012","unstructured":"Aso, H., Ito, S., Mori, A., Morioka, M., Suganuma, N., Kondo, M., et al. (2012). Prostaglandin E2 enhances interleukin-8 production via EP4 receptor in human pulmonary microvascular endothelial cells. American Journal of Physiology\u2014Lung Cellular and Molecular Physiology., 302(2), L266\u2013L273. https:\/\/doi.org\/10.1152\/ajplung.00248.2011","journal-title":"American Journal of Physiology\u2014Lung Cellular and Molecular Physiology."},{"issue":"9","key":"919_CR50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/intimm\/dxz021","volume":"31","author":"K Tsuge","year":"2019","unstructured":"Tsuge, K., Inazumi, T., Shimamoto, A., & Sugimoto, Y. (2019). Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases. International Immunology, 31(9), 597\u2013606. https:\/\/doi.org\/10.1093\/intimm\/dxz021","journal-title":"International Immunology"},{"issue":"9","key":"919_CR51","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.4049\/jimmunol.172.9.5676","volume":"172","author":"RM McLoughlin","year":"2004","unstructured":"McLoughlin, R. M., Hurst, S. M., Nowell, M. A., Harris, D. A., Horiuchi, S., Morgan, L. W., et al. (2004). Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. Journal of Immunology., 172(9), 5676\u20135683. https:\/\/doi.org\/10.4049\/jimmunol.172.9.5676","journal-title":"Journal of Immunology."},{"issue":"8","key":"919_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255335","volume":"16","author":"M Ricke-Hoch","year":"2021","unstructured":"Ricke-Hoch, M., Stelling, E., Lasswitz, L., Gunesch, A. P., Kasten, M., Zapatero-Belinchon, F. J., et al. (2021). Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS ONE, 16(8), e0255335. https:\/\/doi.org\/10.1371\/journal.pone.0255335","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"919_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/A:1019927616000","volume":"238","author":"S Nakao","year":"2002","unstructured":"Nakao, S., Ogtata, Y., Shimizu, E., Yamazaki, M., Furuyama, S., & Sugiya, H. (2002). Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts. Molecular and Cellular Biochemistry, 238(1\u20132), 11\u201318. https:\/\/doi.org\/10.1023\/A:1019927616000","journal-title":"Molecular and Cellular Biochemistry"},{"key":"919_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.025","author":"N Kaneko","year":"2020","unstructured":"Kaneko, N., Kuo, H. H., Boucau, J., Farmer, J. R., Allard-Chamard, H., Mahajan, V. S., et al. (2020). Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.08.025","journal-title":"Cell"},{"issue":"3","key":"919_CR55","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jaci.2015.11.012","volume":"137","author":"K Jandl","year":"2016","unstructured":"Jandl, K., Stacher, E., Balint, Z., Sturm, E. M., Maric, J., Peinhaupt, M., et al. (2016). Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung. Journal of Allergy and Clinical Immunology., 137(3), 833\u2013843. https:\/\/doi.org\/10.1016\/j.jaci.2015.11.012","journal-title":"Journal of Allergy and Clinical Immunology."},{"key":"919_CR56","doi-asserted-by":"publisher","DOI":"10.37421\/jmgm.2020.14.457","author":"A Gupta","year":"2020","unstructured":"Gupta, A., Kalantar-Zadeh, K., & Reddy, S. T. (2020). Ramatroban as a novel immunotherapy for COVID-19. Journal of Molecular and Genetic Medicine. https:\/\/doi.org\/10.37421\/jmgm.2020.14.457","journal-title":"Journal of Molecular and Genetic Medicine"},{"issue":"4","key":"919_CR57","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/infdis\/jir804","volume":"205","author":"A Cloutier","year":"2012","unstructured":"Cloutier, A., Marois, I., Cloutier, D., Verreault, C., Cantin, A. M., & Richter, M. V. (2012). The prostanoid 15-deoxy-\u039412,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. The Journal of Infectious Diseases., 205(4), 621\u2013630. https:\/\/doi.org\/10.1093\/infdis\/jir804","journal-title":"The Journal of Infectious Diseases."},{"issue":"11","key":"919_CR58","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00228-020-02941-w","volume":"76","author":"M Hoxha","year":"2020","unstructured":"Hoxha, M. (2020). What about COVID-19 and arachidonic acid pathway? European Journal of Clinical Pharmacology., 76(11), 1501\u20131504. https:\/\/doi.org\/10.1007\/s00228-020-02941-w","journal-title":"European Journal of Clinical Pharmacology."},{"issue":"12","key":"919_CR59","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1172\/JCI59777","volume":"121","author":"J Zhao","year":"2011","unstructured":"Zhao, J., Zhao, J., Legge, K., & Perlman, S. (2011). Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. The Journal of Clinical Investigation., 121(12), 4921\u20134930. https:\/\/doi.org\/10.1172\/JCI59777","journal-title":"The Journal of Clinical Investigation."},{"key":"919_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.904020","volume":"13","author":"ML Ogletree","year":"2022","unstructured":"Ogletree, M. L., Chander Chiang, K., Kulshrestha, R., Agarwal, A., Agarwal, A., & Gupta, A. (2022). Treatment of COVID-19 pneumonia and acute respiratory distress with ramatroban, a thromboxane A2 and prostaglandin D2 receptor antagonist: A four-patient case series report. Frontiers in Pharmacology, 13, 904020. https:\/\/doi.org\/10.3389\/fphar.2022.904020","journal-title":"Frontiers in Pharmacology"},{"issue":"1\u20133","key":"919_CR61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejphar.2011.07.046","volume":"669","author":"AK Larsson","year":"2011","unstructured":"Larsson, A. K., Hagfj\u00e4rd, A., Dahl\u00e9n, S. E., & Adner, M. (2011). Prostaglandin D2 induces contractions through activation of TP receptors in peripheral lung tissue from the guinea pig. European Journal of Pharmacology, 669(1\u20133), 136\u2013142. https:\/\/doi.org\/10.1016\/j.ejphar.2011.07.046","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"919_CR62","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100540R","volume":"35","author":"Archam bault, A. S., Zaid, Y., Rako","year":"2021","unstructured":"Archam bault, A. S., Zaid, Y., Rakotoarivelo, V., Turcotte, C., Dore, E., Dubuc, I., et al. (2021). High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients. FASEB Journal., 35(6), e21666. https:\/\/doi.org\/10.1096\/fj.202100540R","journal-title":"FASEB Journal."},{"issue":"7908","key":"919_CR63","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41586-022-04630-3","volume":"605","author":"LR Wong","year":"2022","unstructured":"Wong, L. R., Zheng, J., Wilhelmsen, K., Li, K., Ortiz, M. E., Schnicker, N. J., et al. (2022). Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19. Nature, 605(7908), 146\u2013151. https:\/\/doi.org\/10.1038\/s41586-022-04630-3","journal-title":"Nature"},{"issue":"6","key":"919_CR64","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/j.jvs.2022.03.658","volume":"75","author":"H Verma","year":"2022","unstructured":"Verma, H., Mendiratta, N., & Tripathi, R. K. (2022). Prostaglandin E1 infusion could improve outcomes in COVID-related limb ischemia\u2014a single operator series of 17 patients. Journal of Vascular Surgery, 75(6), e291\u2013e292. https:\/\/doi.org\/10.1016\/j.jvs.2022.03.658","journal-title":"Journal of Vascular Surgery"},{"issue":"12","key":"919_CR65","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1073\/pnas.83.12.4175","volume":"83","author":"T Shimizu","year":"1986","unstructured":"Shimizu, T., Izumi, T., Seyama, Y., & Tadokoro, K. (1986). Radmark O, Samuelsson B, Characterization of leukotriene A4 synthase from murine mast cells: Evidence for its identity to arachidonate 5-lipoxygenase. Proc Natl Acad Sci U S A., 83(12), 4175\u20134179. https:\/\/doi.org\/10.1073\/pnas.83.12.4175","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"10","key":"919_CR66","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJM199009063231006","volume":"323","author":"RA Lewis","year":"1990","unstructured":"Lewis, R. A., Austen, K. F., & Soberman, R. J. (1990). Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. New England Journal of Medicine., 323(10), 645\u2013655. https:\/\/doi.org\/10.1056\/NEJM199009063231006","journal-title":"New England Journal of Medicine."},{"issue":"6","key":"919_CR67","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2222.2006.02498.x","volume":"36","author":"M Peters-Golden","year":"2006","unstructured":"Peters-Golden, M., Gleason, M. M., & Togias, A. (2006). Cysteinyl leukotrienes: Multi-functional mediators in allergic rhinitis. Clinical and Experimental Allergy, 36(6), 689\u2013703. https:\/\/doi.org\/10.1111\/j.1365-2222.2006.02498.x","journal-title":"Clinical and Experimental Allergy"},{"issue":"7","key":"919_CR68","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.RES.0000264498.60702.0d","volume":"100","author":"M B\u00e4ck","year":"2007","unstructured":"B\u00e4ck, M., Sultan, A., Ovchinnikova, O., & Hansson, G. K. (2007). 5-Lipoxygenase-activating protein: A potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circulation Research., 100(7), 946\u2013949. https:\/\/doi.org\/10.1161\/01.RES.0000264498.60702.0d","journal-title":"Circulation Research."},{"issue":"6000","key":"919_CR69","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.1190594","volume":"330","author":"RJ Snelgrove","year":"2010","unstructured":"Snelgrove, R. J., Jackson, P. L., Hardison, M. T., Noerager, B. D., Kinloch, A., Gaggar, A., et al. (2010). A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science, 330(6000), 90\u201394. https:\/\/doi.org\/10.1126\/science.1190594","journal-title":"Science"},{"issue":"3","key":"919_CR70","first-page":"1514","volume":"271","author":"P Wheelan","year":"1994","unstructured":"Wheelan, P., Sala, A., Folco, G., Nicosia, S., Falck, J. R., Bhatt, R. K., et al. (1994). Stereochemical analysis and biological activity of 3-hydroxy-leukotriene B4: A metabolite from ethanol-treated rat hepatocytes. Journal of Pharmacology and Experimental Therapeutics, 271(3), 1514\u20131519.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"17","key":"919_CR71","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1073\/pnas.80.17.5425","volume":"80","author":"F Fitzpatrick","year":"1983","unstructured":"Fitzpatrick, F., Haeggstrom, J., Granstrom, E., & Samuelsson, B. (1983). Metabolism of leukotriene A4 by an enzyme in blood plasma: A possible leukotactic mechanism. Proceedings of the National Academy of Sciences of the United States of America., 80(17), 5425\u20135429. https:\/\/doi.org\/10.1073\/pnas.80.17.5425","journal-title":"Proceedings of the National Academy of Sciences of the United States of America."},{"issue":"3","key":"919_CR72","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1172\/JCI117053","volume":"93","author":"DA Munafo","year":"1994","unstructured":"Munafo, D. A., Shindo, K., Baker, J. R., & Bigby, T. D. (1994). Leukotriene A4 hydrolase in human bronchoalveolar lavage fluid. Journal of Clinical Investigation., 93(3), 1042\u20131050. https:\/\/doi.org\/10.1172\/JCI117053","journal-title":"Journal of Clinical Investigation."},{"key":"919_CR73","doi-asserted-by":"publisher","first-page":"44449","DOI":"10.1038\/srep44449","volume":"7","author":"CM Low","year":"2017","unstructured":"Low, C. M., Akthar, S., Patel, D. F., Loser, S., Wong, C. T., Jackson, P. L., et al. (2017). The development of novel LTA4H modulators to selectively target LTB4 generation. Scientific Reports., 7, 44449. https:\/\/doi.org\/10.1038\/srep44449","journal-title":"Scientific Reports."},{"issue":"49","key":"919_CR74","doi-asserted-by":"publisher","first-page":"50639","DOI":"10.1074\/jbc.R400027200","volume":"279","author":"JZ Haeggstrom","year":"2004","unstructured":"Haeggstrom, J. Z. (2004). Leukotriene A4 hydrolase\/aminopeptidase, the gatekeeper of chemotactic leukotriene B4 biosynthesis. Journal of Biological Chemistry., 279(49), 50639\u201350642. https:\/\/doi.org\/10.1074\/jbc.R400027200","journal-title":"Journal of Biological Chemistry."},{"key":"919_CR75","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.smim.2017.08.007","volume":"33","author":"L Bhatt","year":"2017","unstructured":"Bhatt, L., Roinestad, K., Van, T., & Springman, E. B. (2017). Recent advances in clinical development of leukotriene B4 pathway drugs. Seminars in Immunology., 33, 65\u201373. https:\/\/doi.org\/10.1016\/j.smim.2017.08.007","journal-title":"Seminars in Immunology."},{"key":"919_CR76","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3389\/fphar.2020.01214","volume":"11","author":"CD Funk","year":"2020","unstructured":"Funk, C. D., & Ardakani, A. (2020). A novel strategy to mitigate the hyperinflammatory response to COVID-19 by targeting leukotrienes. Frontiers in Pharmacology., 11, 1214. https:\/\/doi.org\/10.3389\/fphar.2020.01214","journal-title":"Frontiers in Pharmacology."},{"issue":"4","key":"919_CR77","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1586\/17476348.2014.908715","volume":"8","author":"M Watanabe","year":"2014","unstructured":"Watanabe, M., Machida, K., & Inoue, H. (2014). A turn on and a turn off: BLT1 and BLT2 mechanisms in the lung. Expert Review of Respiratory Medicine, 8(4), 381\u2013383. https:\/\/doi.org\/10.1586\/17476348.2014.908715","journal-title":"Expert Review of Respiratory Medicine"},{"key":"919_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.610132","volume":"7","author":"L Aigner","year":"2020","unstructured":"Aigner, L., Pietrantonio, F., Bessa de Sousa, D. M., Michael, J., Schuster, D., Reitsamer, H. A., et al. (2020). The leukotriene receptor antagonist montelukast as a potential COVID-19 therapeutic. Frontiers in Molecular Biosciences., 7, 610132. https:\/\/doi.org\/10.3389\/fmolb.2020.610132","journal-title":"Frontiers in Molecular Biosciences."},{"issue":"1","key":"919_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2003.12.012","volume":"50","author":"V Capra","year":"2004","unstructured":"Capra, V. (2004). Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacological Research., 50(1), 1\u201311. https:\/\/doi.org\/10.1016\/j.phrs.2003.12.012","journal-title":"Pharmacological Research."},{"key":"919_CR80","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1038\/srep03274","volume":"3","author":"E Duah","year":"2013","unstructured":"Duah, E., Adapala, R. K., Al-Azzam, N., Kondeti, V., Gombedza, F., Thodeti, C. K., et al. (2013). Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT(2) and CysLT(1) receptors. Scientific Reports., 3, 3274. https:\/\/doi.org\/10.1038\/srep03274","journal-title":"Scientific Reports."},{"issue":"3","key":"919_CR81","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4049\/jimmunol.173.3.1503","volume":"173","author":"Y Kanaoka","year":"2004","unstructured":"Kanaoka, Y., & Boyce, J. A. (2004). Cysteinyl leukotrienes and their receptors: Cellular distribution and function in immune and inflammatory responses. Journal of Immunology., 173(3), 1503\u20131510. https:\/\/doi.org\/10.4049\/jimmunol.173.3.1503","journal-title":"Journal of Immunology."},{"issue":"6","key":"919_CR82","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S1081-1206(10)61326-9","volume":"94","author":"S Maeba","year":"2005","unstructured":"Maeba, S., Ichiyama, T., Ueno, Y., Makata, H., Matsubara, T., & Furukawa, S. (2005). Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules. Annals of Allergy, Asthma & Immunology., 94(6), 670\u2013674. https:\/\/doi.org\/10.1016\/S1081-1206(10)61326-9","journal-title":"Annals of Allergy, Asthma & Immunology."},{"key":"919_CR83","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/536156","volume":"2012","author":"B Auner","year":"2012","unstructured":"Auner, B., Geiger, E. V., Henrich, D., Lehnert, M., Marzi, I., & Relja, B. (2012). Circulating leukotriene B4 identifies respiratory complications after trauma. Mediators of Inflammation., 2012, 536156. https:\/\/doi.org\/10.1155\/2012\/536156","journal-title":"Mediators of Inflammation."},{"issue":"6","key":"919_CR84","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4172\/2161-105X.1000435","volume":"7","author":"G Takahashi","year":"2017","unstructured":"Takahashi, G., Shibata, S., & Endo, S. (2017). Eicosanoids as risk and prognostic factors for acute respiratory distress syndrome in sepsis patients. J Pulm Respir Med., 7(6), 435. https:\/\/doi.org\/10.4172\/2161-105X.1000435","journal-title":"J Pulm Respir Med."},{"issue":"1","key":"919_CR85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00003246-200001000-00009","volume":"28","author":"M Amat","year":"2000","unstructured":"Amat, M., Barcons, M., Mancebo, J., Mateo, J., Oliver, A., Mayoral, J.-F., et al. (2000). Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: Mortality prognostic study. Critical Care Medicine., 28(1), 57\u201362. https:\/\/doi.org\/10.1097\/00003246-200001000-00009","journal-title":"Critical Care Medicine."},{"issue":"3","key":"919_CR86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0952-3278(91)90162-x","volume":"43","author":"JY Westcott","year":"1991","unstructured":"Westcott, J. Y., Thomas, R. B., & Voelkel, N. F. (1991). Elevated urinary leukotriene E4 excretion in patients with ARDS and severe burns. Prostaglandins Leukotrienes and Essential Fatty Acids, 43(3), 151\u2013158. https:\/\/doi.org\/10.1016\/0952-3278(91)90162-x","journal-title":"Prostaglandins Leukotrienes and Essential Fatty Acids"},{"issue":"3","key":"919_CR87","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.pharmthera.2006.05.009","volume":"112","author":"O Werz","year":"2006","unstructured":"Werz, O., & Steinhilber, D. (2006). Therapeutic options for 5-lipoxygenase inhibitors. Pharmacology & Therapeutics, 112(3), 701\u2013718. https:\/\/doi.org\/10.1016\/j.pharmthera.2006.05.009","journal-title":"Pharmacology & Therapeutics"},{"key":"919_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071353","author":"MJ Tsai","year":"2017","unstructured":"Tsai, M. J., Chang, W. A., Tsai, P. H., Wu, C. Y., Ho, Y. W., Yen, M. C., et al. (2017). Montelukast induces apoptosis-inducing factor-mediated cell death of lung cancer cells. International Journal of Molecular Science. https:\/\/doi.org\/10.3390\/ijms18071353","journal-title":"International Journal of Molecular Science"},{"issue":"Suppl","key":"919_CR89","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","volume":"50","author":"AA Spector","year":"2009","unstructured":"Spector, A. A. (2009). Arachidonic acid cytochrome P450 epoxygenase pathway. Journal of Lipid Research, 50(Suppl), S52\u2013S56. https:\/\/doi.org\/10.1194\/jlr.R800038-JLR200","journal-title":"Journal of Lipid Research"},{"key":"919_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00239","author":"S Tacconelli","year":"2014","unstructured":"Tacconelli, S., & Patrignani, P. (2014). Inside epoxyeicosatrienoic acids and cardiovascular disease. Frontiers in Pharmacology. https:\/\/doi.org\/10.3389\/fphar.2014.00239","journal-title":"Frontiers in Pharmacology"},{"issue":"23","key":"919_CR91","doi-asserted-by":"publisher","first-page":"E3240","DOI":"10.1073\/pnas.1521453113","volume":"113","author":"DW Gilroy","year":"2016","unstructured":"Gilroy, D. W., Edin, M. L., De Maeyer, R. P., Bystrom, J., Newson, J., Lih, F. B., et al. (2016). CYP450-derived oxylipins mediate inflammatory resolution. Proceedings of the National Academy of Sciences of the United States of America., 113(23), E3240\u2013E3249. https:\/\/doi.org\/10.1073\/pnas.1521453113","journal-title":"Proceedings of the National Academy of Sciences of the United States of America."},{"key":"919_CR92","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/605101","volume":"2012","author":"SJ Thomson","year":"2012","unstructured":"Thomson, S. J., Askari, A., & Bishop-Bailey, D. (2012). Anti-inflammatory effects of epoxyeicosatrienoic acids. International Journal of Vascular Medicine., 2012, 605101. https:\/\/doi.org\/10.1155\/2012\/605101","journal-title":"International Journal of Vascular Medicine."},{"issue":"2","key":"919_CR93","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1096\/fj.10-171488","volume":"25","author":"Y Deng","year":"2011","unstructured":"Deng, Y., Edin, M. L., Theken, K. N., Schuck, R. N., Flake, G. P., Kannon, M. A., et al. (2011). Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. FASEB Journal., 25(2), 703\u2013713. https:\/\/doi.org\/10.1096\/fj.10-171488","journal-title":"FASEB Journal."},{"issue":"2","key":"919_CR94","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000430113","volume":"36","author":"G Yu","year":"2015","unstructured":"Yu, G., Zeng, X., Wang, H., Hou, Q., Tan, C., Xu, Q., et al. (2015). 14,15-epoxyeicosatrienoic acid suppresses cigarette smoke extract-induced apoptosis in lung epithelial cells by inhibiting endoplasmic reticulum stress. Cellular Physiology and Biochemistry., 36(2), 474\u2013486. https:\/\/doi.org\/10.1159\/000430113","journal-title":"Cellular Physiology and Biochemistry."},{"issue":"1","key":"919_CR95","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/JCI61453","volume":"122","author":"D Wang","year":"2012","unstructured":"Wang, D., & Dubois, R. N. (2012). Epoxyeicosatrienoic acids: A double-edged sword in cardiovascular diseases and cancer. The Journal of Clinical Investigation, 122(1), 19\u201322. https:\/\/doi.org\/10.1172\/JCI61453","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"919_CR96","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/FJC.0b013e318273b007","volume":"61","author":"J Bellien","year":"2013","unstructured":"Bellien, J., & Joannides, R. (2013). Epoxyeicosatrienoic acid pathway in human health and diseases. Journal of Cardiovascular Pharmacology., 61(3), 188\u2013196. https:\/\/doi.org\/10.1097\/FJC.0b013e318273b007","journal-title":"Journal of Cardiovascular Pharmacology."},{"issue":"35","key":"919_CR97","doi-asserted-by":"publisher","first-page":"12746","DOI":"10.1073\/pnas.1404372111","volume":"111","author":"PC Norris","year":"2014","unstructured":"Norris, P. C., Gosselin, D., Reichart, D., Glass, C. K., & Dennis, E. A. (2014). Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. Proc Natl Acad Sci U S A., 111(35), 12746\u201312751. https:\/\/doi.org\/10.1073\/pnas.1404372111","journal-title":"Proc Natl Acad Sci U S A."},{"key":"919_CR98","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149236","author":"JM Snider","year":"2021","unstructured":"Snider, J. M., You, J. K., Wang, X., Snider, A. J., Hallmark, B., Zec, M. M., et al. (2021). Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI149236","journal-title":"Journal of Clinical Investigation"},{"issue":"23","key":"919_CR99","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1177\/15353702211028560","volume":"246","author":"FA Kuypers","year":"2021","unstructured":"Kuypers, F. A., Rostad, C. A., Anderson, E. J., Chahroudi, A., Jaggi, P., Wrammert, J., et al. (2021). Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C). Experimental Biology and Medicine., 246(23), 2543\u20132552. https:\/\/doi.org\/10.1177\/15353702211028560","journal-title":"Experimental Biology and Medicine."},{"issue":"15","key":"919_CR100","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1021\/bi602652j","volume":"46","author":"A Trostchansky","year":"2007","unstructured":"Trostchansky, A., Souza, J. M., Ferreira, A., Ferrari, A., Blanco, F., & Trujillo, M. (2007). Synthesis, isomer characterization, and anti-Inflammatory properties of nitroarachidonate. Biochemistry, 46(15), 45\u201353.","journal-title":"Biochemistry"},{"key":"919_CR101","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s43450-021-00213-x","volume":"32","author":"PK Baral","year":"2022","unstructured":"Baral, P. K., Amin, M. T., Rashid, M. M. O., & Hossain, M. S. (2022). Assessement of polyunsaturated fatty acids on COVID-19 associated risk reduction. Brazilian Journal of Pharmacognosy., 32, 50\u201364. https:\/\/doi.org\/10.1007\/s43450-021-00213-x","journal-title":"Brazilian Journal of Pharmacognosy."},{"key":"919_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2021.106539","volume":"154","author":"MAR Ripon","year":"2021","unstructured":"Ripon, M. A. R., Bhowmik, D. R., Amin, M. T., & Hossain, M. S. (2021). Role of Arachidonic cascade in COVID-19 infection. Prostaglandin and Other lipid mediators., 154, 106539. https:\/\/doi.org\/10.1016\/j.prostaglandins.2021.106539","journal-title":"Prostaglandin and Other lipid mediators."},{"key":"919_CR103","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2022","unstructured":"Beigel, J. H., Tomashek, K. M., Dodd, L. E., Metha, A. K., et al. (2022). Remidisivir for the traetment of COVID-19, Final Report. New Enland Journal of Medicine., 383, 1813\u20131826.","journal-title":"New Enland Journal of Medicine."},{"key":"919_CR104","doi-asserted-by":"publisher","unstructured":"Navabshan, I., Sakthivel, B., Pandiyan, R., Antoniraj, M. G., Dharmaraj, S., Ashokkumar, V., Khoo, K.S., Chew, K.W,. Sugumaran, A., Show, P.L. (2021) Computational lock and key and dynamic trajectory analysis of natural biophors against COVID-19 spike protein to identify effective lead molecules. Mol Biotechnol. Oct;63(10):898\u2013908. doi: https:\/\/doi.org\/10.1007\/s12033-021-00358-z. Epub 2021 Jun 22. Erratum in: Mol Biotechnol. 2021 Aug 10;: PMID: 34159564; PMCID: PMC8219180.","DOI":"10.1007\/s12033-021-00358-z"},{"issue":"4","key":"919_CR105","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.bbrc.2015.11.129","volume":"469","author":"JH Park","year":"2016","unstructured":"Park, J. H., Park, E. B., Lee, J. Y., & Min, J. Y. (2016). Identification of novel membrane-associated prostaglandin E synthase-1 (mPGES-1) inhibitors with anti-influenza activities in vitro. Biochemical and Biophysical Research Communications, 469(4), 848\u2013855. https:\/\/doi.org\/10.1016\/j.bbrc.2015.11.129","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"919_CR106","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1084\/jem.20061617","volume":"204","author":"S Gross","year":"2007","unstructured":"Gross, S., Tilly, P., Hentsch, D., Vonesch, J. L., & Fabre, J. E. (2007). Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors. Journal of Experimental Medicine., 204(2), 311\u2013320. https:\/\/doi.org\/10.1084\/jem.20061617","journal-title":"Journal of Experimental Medicine."},{"issue":"1","key":"919_CR107","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/cpt.1197","volume":"105","author":"MCH Janssen","year":"2019","unstructured":"Janssen, M. C. H., Koene, S., de Laat, P., Hemelaar, P., Pickkers, P., Spaans, E., et al. (2019). The KHENERGY Study: Safety and Efficacy of KH176 in Mitochondrial m.3243A>G Spectrum Disorders. Clinical Pharmacology & Therapeutics., 105(1), 101\u2013111. https:\/\/doi.org\/10.1002\/cpt.1197","journal-title":"Clinical Pharmacology & Therapeutics."},{"issue":"1","key":"919_CR108","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1038\/s41598-018-24900-3","volume":"8","author":"J Beyrath","year":"2018","unstructured":"Beyrath, J., Pellegrini, M., Renkema, H., Houben, L., Pecheritsyna, S., van Zandvoort, P., et al. (2018). KH176 safeguards mitochondrial diseased cells from redox stress-induced cell death by interacting with the thioredoxin system\/peroxiredoxin enzyme machinery. Scientific Reports., 8(1), 6577. https:\/\/doi.org\/10.1038\/s41598-018-24900-3","journal-title":"Scientific Reports."},{"issue":"4","key":"919_CR109","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.bmcl.2011.12.107","volume":"22","author":"J Liu","year":"2012","unstructured":"Liu, J., Wang, Y., Johnson, M. G., Li, A.-R., Shen, W., Wang, X., et al. (2012). Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonists. Bioorganic & Medicinal Chemistry Letters., 22(4), 1686\u20131689. https:\/\/doi.org\/10.1016\/j.bmcl.2011.12.107","journal-title":"Bioorganic & Medicinal Chemistry Letters."},{"issue":"1","key":"919_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0090-6980(91)90088-w","volume":"42","author":"A Sala","year":"1991","unstructured":"Sala, A., Murphy, R. C., & Voelkel, N. F. (1991). Direct airway injury results in elevated levels of sulfidopeptide leukotrienes, detectable in airway secretions. Prostaglandins, 42(1), 1\u20137. https:\/\/doi.org\/10.1016\/0090-6980(91)90088-w","journal-title":"Prostaglandins"},{"issue":"2","key":"919_CR111","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1164\/ajrccm\/144.2.263","volume":"144","author":"GR Bernard","year":"1991","unstructured":"Bernard, G. R., Korley, V., Chee, P., Swindell, B., Ford-Hutchinson, A. W., & Tagari, P. (1991). Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. The American Review of Respiratory Disease., 144(2), 263\u2013267. https:\/\/doi.org\/10.1164\/ajrccm\/144.2.263","journal-title":"The American Review of Respiratory Disease."},{"issue":"5","key":"919_CR112","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"C Wu","year":"2020","unstructured":"Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., et al. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B., 10(5), 766\u2013788. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008","journal-title":"Acta Pharmaceutica Sinica B."},{"key":"919_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109883","volume":"143","author":"MQ Almerie","year":"2020","unstructured":"Almerie, M. Q., & Kerrigan, D. D. (2020). The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast. Medical Hypotheses., 143, 109883. https:\/\/doi.org\/10.1016\/j.mehy.2020.109883","journal-title":"Medical Hypotheses."},{"key":"919_CR114","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pharmthera.2017.10.016","volume":"183","author":"WH Schunck","year":"2018","unstructured":"Schunck, W. H., Konkel, A., Fischer, R., & Weylandt, K. H. (2018). Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases. Pharmacology & Therapeutics, 183, 177\u2013204. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.10.016","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"919_CR115","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1073\/pnas.14225901","volume":"112","author":"C Lopez-Vicario","year":"2015","unstructured":"Lopez-Vicario, C., Alcaraz-Quiles, J., Garcia-Alonso, V., Rius, B., Hwang, S. H., Titos, E., et al. (2015). Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides. Proceedings of the National Academy of Sciences of the United States of America., 112(2), 536\u2013541. https:\/\/doi.org\/10.1073\/pnas.14225901","journal-title":"Proceedings of the National Academy of Sciences of the United States of America."},{"issue":"7","key":"919_CR116","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.21873\/anticanres.13513","volume":"39","author":"R Xia","year":"2019","unstructured":"Xia, R., Sun, L., Liao, J., Li, H., You, X., Xu, D., et al. (2019). Inhibition of pancreatic carcinoma growth through enhancing \u03c9-3 epoxy polyunsaturated fatty acid profile by inhibition of soluble epoxide hydrolase. Anticancer Research., 39(7), 3651\u20133660. https:\/\/doi.org\/10.21873\/anticanres.13513","journal-title":"Anticancer Research."},{"issue":"39","key":"919_CR117","doi-asserted-by":"publisher","first-page":"36059","DOI":"10.1074\/jbc.R100030200","volume":"276","author":"DC Zeldin","year":"2001","unstructured":"Zeldin, D. C. (2001). Epoxygenase pathways of arachidonic acid metabolism. Journal of Biological Chemistry, 276(39), 36059\u201336062. https:\/\/doi.org\/10.1074\/jbc.R100030200","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"919_CR118","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","volume":"8","author":"JD Imig","year":"2009","unstructured":"Imig, J. D., & Hammock, B. D. (2009). Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nature Reviews Drug Discovery., 8(10), 794\u2013805. https:\/\/doi.org\/10.1038\/nrd2875","journal-title":"Nature Reviews Drug Discovery."},{"issue":"5","key":"919_CR119","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/SHK.0000000000000767","volume":"47","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y., Liu, T., Duan, J. X., Li, P., Sun, G. Y., Liu, Y. P., et al. (2017). Soluble epoxide hydrolase inhibitor attenuates lipopolysaccharide-induced acute lung injury and improves survival in mice. Shock, 47(5), 638\u2013645. https:\/\/doi.org\/10.1097\/SHK.0000000000000767","journal-title":"Shock"},{"issue":"8","key":"919_CR120","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1164\/rccm.201403-0544OC","volume":"190","author":"E Ono","year":"2014","unstructured":"Ono, E., Dutile, S., Kazani, S., Wechsler, M. E., Yang, J., Hammock, B. D., et al. (2014). Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. American Journal of Respiratory and Critical Care Medicine., 190(8), 886\u2013897. https:\/\/doi.org\/10.1164\/rccm.201403-0544OC","journal-title":"American Journal of Respiratory and Critical Care Medicine."},{"issue":"3","key":"919_CR121","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1124\/jpet.116.232108","volume":"357","author":"SK Goswami","year":"2016","unstructured":"Goswami, S. K., Wan, D., Yang, J., Trindade da Silva, C. A., Morisseau, C., Kodani, S. D., et al. (2016). Anti-ulcer efficacy of soluble epoxide hydrolase inhibitor TPPU on diclofenac-induced intestinal ulcers. The Journal of Pharmacology and Experimental Therapeutics., 357(3), 529\u2013536. https:\/\/doi.org\/10.1124\/jpet.116.232108","journal-title":"The Journal of Pharmacology and Experimental Therapeutics."},{"key":"919_CR122","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ijcard.2016.08.233","volume":"223","author":"R Ghosh","year":"2016","unstructured":"Ghosh, R., Goswami, S. K., Feitoza, L., Hammock, B., & Gomes, A. V. (2016). Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts. International Journal of Cardiology., 223, 923\u2013935. https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.233","journal-title":"International Journal of Cardiology."},{"issue":"7","key":"919_CR123","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1172\/JCI127282","volume":"129","author":"D Panigrahy","year":"2019","unstructured":"Panigrahy, D., Gartung, A., Yang, J., Yang, H., Gilligan, M. M., Sulciner, M. L., et al. (2019). Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases. The Journal of Clinical Investigation, 129(7), 2964\u20132979. https:\/\/doi.org\/10.1172\/JCI127282","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"919_CR124","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/MOL.0000000000000262","volume":"27","author":"AE Barden","year":"2016","unstructured":"Barden, A. E., Mas, E., & Mori, T. A. (2016). n-3 Fatty acid supplementation and proresolving mediators of inflammation. Current Opinion in Lipidology., 27(1), 26\u201332. https:\/\/doi.org\/10.1097\/MOL.0000000000000262","journal-title":"Current Opinion in Lipidology."},{"issue":"1","key":"919_CR125","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/CIRCRESAHA.119.315506","volume":"126","author":"PR Souza","year":"2020","unstructured":"Souza, P. R., Marques, R. M., Gomez, E. A., Colas, R. A., De Matteis, R., Zak, A., et al. (2020). Enriched marine oil supplements increase peripheral blood specialized pro-resolving mediators concentrations and reprogram host immune responses: a randomized double-blind placebo-controlled study. Circulation Research., 126(1), 75\u201390. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315506","journal-title":"Circulation Research."},{"key":"919_CR126","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.plefa.2016.01.001","volume":"138","author":"PC Norris","year":"2018","unstructured":"Norris, P. C., Arnardottir, H., Sanger, J. M., Fichtner, D., Keyes, G. S., & Serhan, C. N. (2018). Resolvin D3 multi-level proresolving actions are host protective during infection. Prostaglandins, Leukotrienes and Essential Fatty Acids., 138, 81\u201389. https:\/\/doi.org\/10.1016\/j.plefa.2016.01.001","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids."},{"issue":"7268","key":"919_CR127","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/nature08541","volume":"461","author":"M Spite","year":"2009","unstructured":"Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., et al. (2009). Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature, 461(7268), 1287\u20131291. https:\/\/doi.org\/10.1038\/nature08541","journal-title":"Nature"},{"issue":"9","key":"919_CR128","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nm.3911","volume":"21","author":"J Dalli","year":"2015","unstructured":"Dalli, J., Chiang, N., & Serhan, C. N. (2015). Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections. Nature medicine., 21(9), 1071\u20131075. https:\/\/doi.org\/10.1038\/nm.3911","journal-title":"Nature medicine."},{"key":"919_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.624657","volume":"11","author":"H Arnardottir","year":"2020","unstructured":"Arnardottir, H., Pawelzik, S. C., Ohlund, W., U., Artiach, G, Hofmann, R., Reinholdsson, I., et al. (2020). Stimulating the resolution of inflammation through omega-3 polyunsaturated fatty acids in COVID-19: Rationale for the COVID-Omega-F trial. Frontiers in Physiology., 11, 624657. https:\/\/doi.org\/10.3389\/fphys.2020.624657","journal-title":"Frontiers in Physiology."},{"issue":"7813","key":"919_CR130","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/d41586-020-01824-5","volume":"582","author":"H Ledford","year":"2020","unstructured":"Ledford, H. (2020). Coronavirus breakthrough: Dexamethasone is first drug shown to save lives. Nature, 582(7813), 469. https:\/\/doi.org\/10.1038\/d41586-020-01824-5","journal-title":"Nature"},{"key":"919_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.04.004","author":"K Pyrillou","year":"2018","unstructured":"Pyrillou, K., Chairakaki, A. D., Tamvakopoulos, C., & Andreakos, E. (2018). Dexamethasone induces omega3-derived immunoresolvents driving resolution of allergic airway inflammation. Journal of Allergy and Clinical Immunology. https:\/\/doi.org\/10.1016\/j.jaci.2018.04.004","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"919_CR132","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20121268","volume":"210","author":"I Das","year":"2013","unstructured":"Das, I., Png, C. W., Oancea, I., Hasnain, S. Z., Lourie, R., Proctor, M., et al. (2013). Glucocorticoids alleviate intestinal ER stress by enhancing protein folding and degradation of misfolded proteins. Journal of Experimental Medicine., 210(6), 1201\u20131216. https:\/\/doi.org\/10.1084\/jem.20121268","journal-title":"Journal of Experimental Medicine."},{"key":"919_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00265-4","author":"A Raut","year":"2021","unstructured":"Raut, A., & Huy, N. T. (2021). Rising incidence of mucormycosis in patients with COVID-19: Another challenge for India amidst the second wave? The Lancet Respiratory Medicine. https:\/\/doi.org\/10.1016\/S2213-2600(21)00265-4","journal-title":"The Lancet Respiratory Medicine"},{"issue":"6485","key":"919_CR134","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1126\/science.abb8034","volume":"367","author":"GA FitzGerald","year":"2020","unstructured":"FitzGerald, G. A. (2020). Misguided drug advice for COVID-19. Science, 367(6485), 1434. https:\/\/doi.org\/10.1126\/science.abb8034","journal-title":"Science"},{"issue":"5","key":"919_CR135","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008). Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nature Reviews Immunology, 8(5), 349\u2013361. https:\/\/doi.org\/10.1038\/nri2294","journal-title":"Nature Reviews Immunology"},{"issue":"7","key":"919_CR136","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/89759","volume":"2","author":"BD Levy","year":"2001","unstructured":"Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001). Lipid mediator class switching during acute inflammation: Signals in resolution. Nature Immunology., 2(7), 612\u2013619. https:\/\/doi.org\/10.1038\/89759","journal-title":"Nature Immunology."},{"issue":"8","key":"919_CR137","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","volume":"192","author":"CN Serhan","year":"2000","unstructured":"Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000). Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. Journal of Experimental Medicine, 192(8), 1197\u20131204. https:\/\/doi.org\/10.1084\/jem.192.8.1197","journal-title":"Journal of Experimental Medicine"},{"issue":"8","key":"919_CR138","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"CN Serhan","year":"2002","unstructured":"Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., et al. (2002). Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. Journal of Experimental Medicine, 196(8), 1025\u20131037. https:\/\/doi.org\/10.1084\/jem.20020760","journal-title":"Journal of Experimental Medicine"},{"issue":"17","key":"919_CR139","doi-asserted-by":"publisher","first-page":"14677","DOI":"10.1074\/jbc.M300218200","volume":"278","author":"S Hong","year":"2003","unstructured":"Hong, S., Gronert, K., Devchand, P. R., Moussignac, R. L., & Serhan, C. N. (2003). Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. Journal of Biological Chemistry., 278(17), 14677\u201314687. https:\/\/doi.org\/10.1074\/jbc.M300218200","journal-title":"Journal of Biological Chemistry."},{"issue":"9","key":"919_CR140","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13557","volume":"74","author":"M Yousefifard","year":"2020","unstructured":"Yousefifard, M., Zali, A., Zarghi, A., Madani Neishaboori, A., Hosseini, M., & Safari, S. (2020). Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence. International Journal of Clinical Practice, 74(9), e13557. https:\/\/doi.org\/10.1111\/ijcp.13557","journal-title":"International Journal of Clinical Practice"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00919-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00919-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00919-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T06:06:15Z","timestamp":1731045975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00919-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":140,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00919-4","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"type":"print","value":"1073-6085"},{"type":"electronic","value":"1559-0305"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"17 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No, this research uses the secondary data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human Participants and\/or Animals"}},{"value":"Not applicable, this review uses the secondary data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}